The study began in January 2023 with an estimated primary completion date of June 2026 and final study completion in March 2027, enrolling an estimated 84 participants across 77 locations worldwide
AUD, Alcohol use disorder, CUD, cocaine use disorder, NUD, Nicotine use disorder, OUD, Opioid use disorder
Any website or individual claiming to sell retatrutide outside of a trial is not offering a legitimate or safe product
With these new uses, the J Code for semaglutide will need to be updated to reflect its broader applications
A label might read "Semaglutide 12.5 mg / B12 2.5 mg / 2.5 ml." The semaglutide concentration is 12.5 / 2.5 = 5 mg/ml
When you move up to a new dose, the first two to three weeks typically bring more pronounced side effects than the maintenance phase at that dose